Targeting RUNX1 as a novel treatment modality for pulmonary arterial hypertension.
Jeong EM, Pereira M, So EY, Wu KQ, Del Tatto M, Wen S, Dooner MS, Dubielecka PM, Reginato AM, Ventetuolo CE, Quesenberry PJ, Klinger JR, Liang OD.
Jeong EM, et al. Among authors: del tatto m.
Cardiovasc Res. 2022 Dec 29;118(16):3211-3224. doi: 10.1093/cvr/cvac001.
Cardiovasc Res. 2022.
PMID: 35018410
Free PMC article.